...
机译:AR调节的LNCRNA TMPO-AS1的过度表达与肿瘤进展和前列腺癌预后不良相关联
School of Life ScienceFudan UniversityShanghai P.R. China;
School of Life ScienceFudan UniversityShanghai P.R. China;
School of Life ScienceFudan UniversityShanghai P.R. China;
School of Life ScienceFudan UniversityShanghai P.R. China;
School of Life ScienceFudan UniversityShanghai P.R. China;
School of Life ScienceFudan UniversityShanghai P.R. China;
Center of Translational MedicineCentral Hospital of ZiboZibo P.R. China;
Center of Translational MedicineCentral Hospital of ZiboZibo P.R. China;
School of Life ScienceFudan UniversityShanghai P.R. China;
School of Life ScienceFudan UniversityShanghai P.R. China;
Center of Translational MedicineCentral Hospital of ZiboZibo P.R. China;
School of Life ScienceFudan UniversityShanghai P.R. China;
androgen receptor; long non‐coding RNA; prognostic marker; prostate cancer; TMPO‐AS1;
机译:AR调节的LNCRNA TMPO-AS1的过度表达与肿瘤进展和前列腺癌预后不良相关联
机译:lncRNA EGFR AS1的过表达与预后不良有关并促进非小细胞肺癌的化疗耐药性
机译:lncRNA AFAP1-AS1的过表达与预后不良有关,并促进结直肠癌的发生
机译:通过调节M1 / M2巨噬细胞极化,LNCRNA Gas5抑制结肠直肠癌的进展
机译:在不良预后的癌症中,Cadherin-11介导的肿瘤进展和侵袭:可行的治疗靶点。
机译:前列腺肿瘤的过表达1与肿瘤的进展相关并预示着乳腺癌的预后不良
机译:前列腺肿瘤的过表达1与肿瘤的进展相关,并预示着乳腺癌的预后不良
机译:跨越种族的前列腺癌进展的分子决定因素。项目a - 人类5RD5a2基因和前列腺癌进展。项目B - 雄激素受体(aR)在前列腺癌进展中的信号传导。项目C - 前列腺癌进展核心的细胞和分子标记 - 流行病学核心